Vimarsana
Biggest News Aggregation in the World

Page 29 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Achmea Investment Management B.V. Cuts Position in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Achmea Investment Management B.V. Cuts Position in Biogen Inc. (NASDAQ:BIIB)

Achmea Investment Management B.V. trimmed its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.0% during the third quarter, Holdings Channel reports. The institutional investor owned 22,902 shares of the biotechnology company’s stock after selling 961 shares during the quarter. Achmea Investment Management B.V.’s holdings in Biogen were worth $5,886,000 as of […]

Achmea Investment Management B.V. Lowers Stake in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Achmea Investment Management B.V. Lowers Stake in Biogen Inc. (NASDAQ:BIIB)

Achmea Investment Management B.V. decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,902 shares of the biotechnology company’s stock after selling 961 shares during the quarter. Achmea Investment Management B.V.’s holdings […]

Biogen (NASDAQ:BIIB) Rating Increased to Buy at StockNews.com - Vimarsana News

Biogen (NASDAQ:BIIB) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Biogen (NASDAQ:BIIB – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday. BIIB has been the topic of a number of other research reports. Wells Fargo & Company lifted their price target on shares of Biogen from $343.00 to $365.00 and gave […]

Source: wkrb13.com
Biogen (NASDAQ:BIIB) Cut to "Neutral" at UBS Group - Vimarsana News

Biogen (NASDAQ:BIIB) Cut to "Neutral" at UBS Group

UBS Group cut shares of Biogen (NASDAQ:BIIB – Free Report) from a buy rating to a neutral rating in a research report released on Wednesday, MarketBeat Ratings reports. UBS Group currently has $276.00 price objective on the biotechnology company’s stock, down from their prior price objective of $311.00. A number of other equities analysts also […]

Biogen Inc. (NASDAQ:BIIB) Shares Sold by LSV Asset Management - Vimarsana News

Biogen Inc. (NASDAQ:BIIB) Shares Sold by LSV Asset Management

LSV Asset Management cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 344,652 shares of the biotechnology company’s stock after selling 8,772 shares during the period. LSV Asset Management owned approximately 0.24% of Biogen […]